Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017910 · ClinicalTrials.gov registry record
Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients
A clinical trial, sponsored by Sonavex.
- Terminated
- Registry status
- 17
- Enrollment target
NCT04017910: Clinical Trial study, sponsored by Sonavex.
NCT04017910 is a clinical trial that was terminated before completion, run by Sonavex. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04017910 was terminated before completion, sponsored by Sonavex.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This is a two stage, prospective, multi-center study to evaluate the EchoMark and EchoSure devices in patients undergoing peripheral arteriovenous fistula creation for hemodialysis access.
Primary Outcome
Data collection to verify accuracy
Interventions
- DEVICE EchoMark/EchoSure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2021-05-12 |
Why NCT04017910 stopped before completion
NCT04017910 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which EchoMark/EchoSure is the first listed.
NCT04017910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04017910 about?
NCT04017910 is a clinical study titled "Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients". This is a two stage, prospective, multi-center study to evaluate the EchoMark and EchoSure devices in patients undergoing peripheral arteriovenous fistula creation for hemodialysis access.
What is the current status of trial NCT04017910?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2019-12-02. Estimated completion is 2021-05-12.
What interventions are being tested in trial NCT04017910?
The interventions under investigation include: EchoMark/EchoSure (DEVICE).
Who is sponsoring clinical trial NCT04017910?
This trial is sponsored by Sonavex, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI